<p>Two commercially available antibodies targeting either the IFITM1-NTD or the IFITM3-NTD were screened by western blot to assess specificity using HA-tagged IFITM1-3 (M1, M2 and M3) cell lines along with control A549 cells. Proteins were also identified using the HA epitope. Blots were imaged on a Li-COR Odyssey system that uses far-red fluorophore conjugated secondary antibodies. In the overlay image, red represents anti-IFITM-NTD labelling and green represents anti-HA labelling. A) Anti-IFITM1-NTD detects IFITM1 and shows cross-reactivity with IFITM3. B) Anti-IFITM3-NTD detects IFITM3 and has cross-reactivity with IFITM2. VDAC was used as a loading control.</p
(A) Summary of mAb screening by ELISA. Undiluted supernatant from 293T cells transfected with antibo...
(A) Western blot analysis of IFITM3 expression by CD8+ T cells before (0) and after in vitro activat...
<p>Cryo-sections of the IFITM1-HA cells were labelled with anti-HA antibodies and Protein A gold. A)...
<p>Immunofluorescence of A549 cells expressing HA-tagged IFITM1, IFITM2 and IFITM3 (or control A549 ...
<p>Permeabilised IFITM2-HA (A) and IFITM3-HA (B) expressing cells were stained with antibodies again...
<p>Relative areas of each colour were calculated as described in <i>materials and methods</i>. Red r...
<p>A549 cells expressing the indicated c-myc- (A) or flag-tagged (B) IFITM3 isoforms were fixed, per...
<p>C-terminal domain HA-tagged IFITM1, IFITM2, IFITM3 and control A549 cell lines were stained intac...
<p>A) Predicted trypsin cleavage sites in hu IFITM1 CTD (Model 3, <a href="http://www.plosone.org/ar...
<p>A) Alignment of IFITM3 N-terminal amino acids from various species. Bold and underlined text high...
<p>Untagged, wild type IFITM1 or IFITM1-Vstop expression plasmids were transfected into HEK293T cell...
<p>Live A549-IFITM-HA cells were incubated with 5 µg/ml anti-HA at 37°C to allow endocytosis of boun...
Shown are plain HL-1, cells stably overexpressing wildtype of hCD36, and mutant-2, as indicated. Cel...
<p>A549 cells expressing native FL IFITM3, Δ21 IFITM3, or Y20A IFITM3 were fixed, permeabilized, and...
(A) Cartoon and schematic representation of IFITM3-iEGFP fusion protein. EGFP flanked with flexible ...
(A) Summary of mAb screening by ELISA. Undiluted supernatant from 293T cells transfected with antibo...
(A) Western blot analysis of IFITM3 expression by CD8+ T cells before (0) and after in vitro activat...
<p>Cryo-sections of the IFITM1-HA cells were labelled with anti-HA antibodies and Protein A gold. A)...
<p>Immunofluorescence of A549 cells expressing HA-tagged IFITM1, IFITM2 and IFITM3 (or control A549 ...
<p>Permeabilised IFITM2-HA (A) and IFITM3-HA (B) expressing cells were stained with antibodies again...
<p>Relative areas of each colour were calculated as described in <i>materials and methods</i>. Red r...
<p>A549 cells expressing the indicated c-myc- (A) or flag-tagged (B) IFITM3 isoforms were fixed, per...
<p>C-terminal domain HA-tagged IFITM1, IFITM2, IFITM3 and control A549 cell lines were stained intac...
<p>A) Predicted trypsin cleavage sites in hu IFITM1 CTD (Model 3, <a href="http://www.plosone.org/ar...
<p>A) Alignment of IFITM3 N-terminal amino acids from various species. Bold and underlined text high...
<p>Untagged, wild type IFITM1 or IFITM1-Vstop expression plasmids were transfected into HEK293T cell...
<p>Live A549-IFITM-HA cells were incubated with 5 µg/ml anti-HA at 37°C to allow endocytosis of boun...
Shown are plain HL-1, cells stably overexpressing wildtype of hCD36, and mutant-2, as indicated. Cel...
<p>A549 cells expressing native FL IFITM3, Δ21 IFITM3, or Y20A IFITM3 were fixed, permeabilized, and...
(A) Cartoon and schematic representation of IFITM3-iEGFP fusion protein. EGFP flanked with flexible ...
(A) Summary of mAb screening by ELISA. Undiluted supernatant from 293T cells transfected with antibo...
(A) Western blot analysis of IFITM3 expression by CD8+ T cells before (0) and after in vitro activat...
<p>Cryo-sections of the IFITM1-HA cells were labelled with anti-HA antibodies and Protein A gold. A)...